Revenue
2023
2024
2025
Camp4 Therapeutics Corp (CAMP)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $3.5M | $652,000 | $350,000 |
| Research & development | $38.2M | $38.8M | $40.6M |
| Operating expenses | $56.1M | $53.7M | $52.2M |
| Operating income | −$52.6M | −$53.1M | −$51.9M |
| EBITDAderived | −$50.9M | −$51.4M | −$50.2M |
| Net income | −$80.4M | −$51.8M | −$49.3M |
| Basic EPSper diluted share | -$2.65 | -$11.04 | -$124.80 |
| Diluted EPSper diluted share | -$2.65 | -$11.04 | -$124.80 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 11, 2025Form 4 | 5AM Ventures VII, L.P. +6TenPercentOwner | BuyCommon Stock · indirect | 2.94M | $1.53 | $4.50M | 2.94M |
| Sep 11, 2025Form 4 | Gold KellyChief Financial Officer | BuyCommon Stock | 6.1K | $1.65 | $10.0K | 67.9K |
| Sep 11, 2025Form 4 | Mandel-Brehm JoshChief Executive Officer | BuyCommon Stock | 6.1K | $1.65 | $10.0K | 278.4K |
| Sep 11, 2025Form 4 | Maricich YuriChief Medical Officer | BuyCommon Stock | 6.1K | $1.65 | $10.0K | 6.1K |
| Sep 11, 2025Form 4 | Young Richard ADirector | BuyCommon Stock | 15.2K | $1.65 | $25.0K | 170.0K |